References to Primary Literature
- SHUISKE GM: Exp. Opin. Therapeutic Patents (1994) 4: 335–341.
- DAVIES HML, SAIKALI E, HUBY NJS, GILLIATT VJ, MATASI J, SEXTON T, CHILDERS SR: J. Med. Chem. (1994) 37: 1262–1268.
- RUPP A, KOVAR KA, BEUERLE G, RUF C, FOLICERS G:
- •Pharm. Acta He/v. (1994) 68: 235–244. A model for amphetamine-like SSRIs
- GOADSBY PJ, ZAGAMI AS, DONNAN GA, SYMINGTON G, ATHONY M, BLADIN PF, LANCE JW: Lancet (1991) 338: 782–783
- STREET LJ, BAKER R, CASTRO JL, CHAMBERS MS, GUIB-LIN AR, HOBBS SC, MATASSA VG, REEVE AJ, BEER MS, MIDDLEMISS DN: J. Med. Chem. (1993) 36: 1529–1538.
- BEER MS, STANTON JA, BEVAN Y, HEALD A, REEVE, AJ, STREET LJ, MATASSA VG, HARGREAVES RJ, MIDDLEMISS DN: Br. J. Pharmacol. (1993) 110: 1196–1200.
- GLENNON RA, Neurasci. Biobehav. Rev. (1990) 14: 35–47.
- LIN CH, HAADSMA-SVENSSON SR, PHILLIPS G, MCCALL RB, PIERCEY, MF, SMITH MW, SVENSSON K, CARLSSON A, CHIDESTER CG, VON VOIGTLANDER PF: J. Med. Chem. (1993) 36: 2208–2218.
- MILLAN MJ, CANTON H, GOBERT A, LEJEUNE F, RIVE'T JM, BERVOETS K, BROCCO M, WIDDOWSON P, MENNINI T, AUDINOT V: J. Pharmacol. Exp. flier. (1994) 268: 337–352.
- MILLAN MJ, RIVET JM, CANTON H, LEJEUNE F, GOBERT A, WIDDOWSON P, BERVOETS K, BROCCO M, PEGLION JL: Eur. J. Pharmacol. (1993) 230: 99–102.
- ZHUANG Z-P, KUNG M-P, KUNG HF: J. Med. Chem. (1994) 37: 1406–1407.A good review of 5-HT1A pharmacology
- SIMIAND J, KEANE PE, BARNOUIN MC, KEANE M, SOUBR1EP, LE FUR G: Fundam.Pharmacol. (1993) 7: 413–427.
- BACHY A, STEINBERG R, SANTUCCI V, FOURNIER M, LANDI M, HAMON M, MANARA L, KEANE PE, SOUBRIE P, LE FUR G: Fundam. Clin. Pharmacol. (1993) 7: 487–497.
- SONESSON C, BOIJE M, SVENSSON K, EKMAN A, CARLSSON A, ROMERO AG, MARTIN IJ, DUNCAN JN, KING LJ, IXTIKSTROM H: J. Med. Chem. (1993) 36: 3409–3416.
- LIN CH, HAADSMA-SVENSSON SR, LAHTI RA, MCCALL RB, PIERCE, MF, SCHREUR PJ, VON VOIGTLANDER PF, SMITH MW, CHIDESTER CG: J. Med. Chem. (1993) 36: 1053–1068.
- LIN CH, HAADSMA-SVENSSON SR, PHILLIPS G, MCCALL RB, PIERCEY MF, SMITH MW, SVENSSON K, CARLSSON A, CHIDESTER CG, VON VOIGTLANDER PF: J. Med. Chem. (1993) 36: 2208–2218.
- LIN CH, HAADSMA-SVENSSON SR, PHILLIPS G, LAHTI RA,MCCALL RB, PIERCEY MF, SCHREUR PJ, VON VOIGTLAN-DER PF, SMITH MW, CHIDESTER CG: J. Med. Chem. (1993) 36: 1069–1083.
- STJERNLOF P, GULLME M, ELEBRING T, ANDERSSON B,WIKSTROM H, LAGERQUIST S, SVENSSON K, EKMAN A, CARLSSON A, SUNDELL 5:1 Med. Chem. (1993) 36: 2059–2065.
- ROMERO AG, LEIBY JA, MCCALL RB, PIERCEY MF, SMITH MW, HAN F: J. Med. Chem. (1993) 36: 2066–2074.
- YU H, LIU Y, HACKSELL U, LEWANDER T: Eur.J. Pharmacol. (1993) 231: 69–76.
- HACKSELL U, LIU Y, YU H, VALLGARDA J, HOOK BB,JOHANSSON AM, LEWANDER T: Drug Des. Discov. (1993) 9: 287–297. Predictive model for aminotetralin 5-HT1A agonists.
- HERNDON JL, ISMAIEL A, INGHER SP, TEITLER M, GLEN NON RA: 1 Med. Chem. (1992) 35: 4903–4910. Structure-affinity relationships of some ketanserin analogues.
- MOKROSZ JL, CHARAKCHLEVA-MINOL S, PALUCHOWSKA MU, CEGLA MT: Pol. 1 Pharmacol. Pharm. (1992) 44: 595–607. Structure-activity relationships of some 3-chlorophenylpiperidines.
- BOGESO KP, ARNT J, HYFTEL J, PEDERSEN H:J. Med. Chem. (1993) 36: 2761–2770.
- PERREGAARD J, ANDERSEN K, HYTTEL J, SANCHEZ C: J.Med. Chem. (1992) 35: 4813–4822.
- ANDERSEN K, PERREGAARD J, ARNT J, NIELSEN JB, BEGTRUP M: J. Med. Chem. (1992) 35: 4823–4831.
- ISMAEL AM, DE LOS ANGELES J, TEITLER M, INGHER S,GLENNON RAJ Med. Chem. (1993) 36: 2519–2525.
- GROVER GJ, SARGENT CA, DZWONCZYK S, NORMANDIN D.E, ANTONACCIO MI: J. Cardiovasc. Pharmacol. (1993) 22: 664–672.
- BRAMBILLA A, GHIORZI A, PITSIKAS N, BORSINi F: J. Pbarm. Pharmacol. (1993) 45: 841–843.
- PITSIKAS N, BRAMBILLA A, BORSINI F: Neurobiol. Ageing (1993) 14: 561–564.
- PITSIKAS N, BRAMBILLA A, BORSINI F: Pharmacol. Bio-chem. Behav. (1994) 47: 95–99.
- BACHY A, HEAULME M, GIUDICE A, MICHAUD JC, LE-FEVRE IA, SOUILHAC J, MANARA L, EMERIT MB, GOZLAN H, HAMON M: Eur. J. Pharmacol. (1993) 237: 299–309.
- COSTALL B, NAYLOR RJ: int. Clin. Psychopbarmacol. (1993)8 (suppl 2)11–18. A good review of 5-HT4 receptor pharmacology.
- KING Fl), HADLEY MS, JOINER KT, MARTIN RT, SANGER aGJ, SMITH DM, SMITH GE, SMITH P, TURNER DH, WAITSEA: j Med. Chem. (1993) 36: 683–689. Structure activity relationships of some 5-HT.4 ligands.
- GASTER LM, JENNINGS AJ, JOINER GF, KING FD, MULHOL-LAND KR, RAHMAN SK, STARR S, WYMAN PA, WARDLE KR, ELLIS ES: J. Med. Chem. (1993) 36:4121–4123.
- MONGE A, PENA MDC, PALOP JA, CALDER°, JM, ROCA J, GARCIA E, ROMERA G, RIO JD LASHERAS B: J. Med. Chem. (1994) 37: 1320–1326.
- SHEN Y, MONSMA JRFJ, METCALF MA, JOSE PA, HAMBLIN MW, SIBLEY DR: J. Biol. Chem. (1993) 268: 18200–18204.
- MONSMA JR FJ, SHEN Y, WARD RP, HANBLIN MW, SIBLEY DR: Mot. Pharmacol. (1993) 43: 230–237.
References to Patent Literature
- KABI PHARMACIA AB, W09320821 (1993).
- ABBOTT LABS, US5288749 (1994); W09312754 (1993).
- SHIONOGI & CO LTD, EP-580398-A (1994).
- HOECHST-ROUSSEL PHARMA INC, US5300498 (1994).
- SEPRACOR INC, W09403428-A (1994).
- MERCK SHARP & DOHME LTD, W09323396-A (1993).
- MERCK SHARP & DOHME LTD, W09321182 (1993).
- MERCK SHARP & DOHME LTD, EP-573221-A (1993).
- MERCK SHARP & DOHME LTD, EP-581538-A (1994).
- MERCK SHARP & DOHME LTD, W09320066 (1993).
- PFIZER INC, W09320066 (1993).
- PFIZER INC, W09321180 (1993).
- PFIZER INC, W09321177 (1993).
- PFIZER LTD, '0709321178 (1993).
- PFIZER INC, W09410171 (1994).
- PFIZER INC, W09318032 (1993).
- GLAXO GROUP LTD, W09314087 (1993).
- GLAXO GROUP LID, W09408993 (1994).
- ADM ET CO, FR2701026 (1994).
- ASTRA AB, W09321179 (1993).
- MERRELL DOW PHARMA INC, W09406789 (1994).
- PIERREL SPA, W09400441 (1994).
- ADIR ET CO, EP-574313 (1993).
- ADM ET CO, EP-571243 (1993).
- ADIR ET CO, EP-564358-A (1993).
- LILLY IND LTD, EP-585116-A (1994).
- ELI LILLY & CO, EP-565274-A (1993).
- ELI LILLY & CO, EP-590971-A (1994).
- SCIOS NOVA INC, US5250537 (1993).
- MERRELL DOW PHARM INC, W09322309-A (1993).
- MERRELL DOW PHARM INC, US5292752 (1994).
- BRISTOL-MYERS SQUIBB CO, US5256664 (1993).
- BRISTOL-MYERS SQUIBB CO, EP-568437-A (1993).
- 1ST RICERCA FRANCESCO ANGELINI SpA, W0931409(1993).
- H LUNDBECK AS, W09322293 (1993).
- JANSSEN PHARMA NV, W09402462 (1994).
- LEO PHARM PRODUCTS LTD AS, W09406770 (1994).
- SANKYO CO LID, EP-600717-A (1994).
- ER SQUIBB & SONS INC, EP-596449-A (1994).
- MOH SA, US5266571 (1993).
- DAINIPPON SEIYAKA, JP100556 (1994).
- GLAXO GROUP LID, EP-581388-A (1994).
- FARMITALIA CARLO ERBA SRL, W09411347 (1994).
- LAB DEL ESTEVE SA, FR2694292 (1994)
- HOKURIKU PHARM. CO. LTD, JP05320161 (1993).
- GD SEARLE & CO, US5227377 (1993).
- GD SEARLE & CO, US5280029 (1994).
- GD SEARLE & CO, US5234921 (1993).
- DAINIPPON SEIYAKU, JP6135960 (1994).
- SYNTHELABO, EP-591026-A (1994).
- SYNTHELABO, EP-591027-A (1994).
- SYNTHELABO, FR2693194 (1994).
- ELF SANOFI et at, EP-580465-A (1994); EP-591030-A (1994).
- KANEBO LTD, JP06025182 (1994); JP06145152 (1994).
- ADIR ET CO, EP-573360-A (1993).
- F HOFFMANN-LA ROCHE AG, EP-572863-A (1993).
- ANAQUEST INC, US5262537 (1993).
- AR ROBINS CO INC, US5236931 (1993); US5273972 (1993).
- SMITHKLINE BEECHAM PLC, W09407859 (1994).
- SMITHKLINE BEECHAM PLC, W09400113 (1994).
- EISAI CO LTD, EP-5547941A (1993).
- GD SEARLE & CO, W09402482 (1994).
- SMITHKLINE BEECHAM PLC, W09408965 (1994).
- SMITHKLINE BEECHAM PLC, W09408998 (1994).
- SMITHKLINE BEECHAM PLC, W09408995 (1994).
- SMITHKLINE BEECHAM PLC, W09410174 (1994).
- SMITHKLINE BEECHAM PLC, W09408994 (1994).
- GLAXO GROUP LTD, W09320071 (1993).